Unintentional weight loss (UWL) often presents a diagnostic challenge in clinical practice. It is a non-specific symptom associated with a wide range of conditions, from benign to life-threatening. This article aims to provide a comprehensive approach to evaluating unexplained weight loss in clinical practice.
Firstly, a thorough history and physical examination are crucial. This should include a detailed dietary history, medication review, and assessment of psychological factors. It is also important to consider the patient's age, as certain conditions such as malignancies are more common in older adults.
Basic laboratory investigations should include complete blood count, electrolyte panel, liver function tests, thyroid function tests, and urinalysis. Depending on the patient’s history and physical examination, more specific tests may be indicated, such as tumor markers or imaging studies.
In elderly patients, a common cause of UWL is the so-called "anorexia of aging," which is often multifactorial and includes decreased appetite, changes in taste and smell, and social factors. In these cases, a multidisciplinary approach involving dietitians, social workers, and possibly psychiatrists may be beneficial.
Patients with unexplained weight loss should be closely monitored. If initial investigations do not reveal a cause, consider repeating the investigations after a period of time or refer to a specialist. It is also important to monitor the patient's nutritional status and provide nutritional support if needed.
In conclusion, the evaluation of unexplained weight loss is a complex process that requires a systematic approach. A thorough history and physical examination, combined with targeted investigations, can help identify the underlying cause. Multidisciplinary involvement and close follow-up are also crucial in managing these patients.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation